ClinVar Miner

Submissions for variant NM_000179.2(MSH6):c.3436C>T (p.Gln1146Ter) (rs63750356)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
International Society for Gastrointestinal Hereditary Tumours (InSiGHT) RCV000074849 SCV000108061 pathogenic Lynch syndrome 2013-09-05 reviewed by expert panel research Coding sequence variation resulting in a stop codon
Ambry Genetics RCV000561009 SCV000673950 pathogenic Hereditary cancer-predisposing syndrome 2018-05-24 criteria provided, single submitter clinical testing The p.Q1146* pathogenic mutation (also known as c.3436C>T), located in coding exon 5 of the MSH6 gene, results from a C to T substitution at nucleotide position 3436. This changes the amino acid from a glutamine to a stop codon within coding exon 5. This pathogenic mutation was reported in an individual with personal and family history consistent with Muir-Torre syndrome (Mangold E et al. Br. J. Dermatol. 2007 Jan;156(1):158-62). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation.
Invitae RCV000629768 SCV000750724 pathogenic Hereditary nonpolyposis colorectal neoplasms 2017-12-05 criteria provided, single submitter clinical testing This sequence change creates a premature translational stop signal (p.Gln1146*) in the MSH6 gene. It is expected to result in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). This variant has been reported in an individual with suspected Lynch syndrome (PMID: 17199584). ClinVar contains an entry for this variant (Variation ID: 89382). Loss-of-function variants in MSH6 are known to be pathogenic (PMID: 18269114, 24362816). For these reasons, this variant has been classified as Pathogenic.
GeneDx RCV000657654 SCV000779402 pathogenic not provided 2017-06-14 criteria provided, single submitter clinical testing This variant is denoted MSH6 c.3436C>T at the cDNA level and p.Gln1146Ter (Q1146X) at the protein level. The substitution creates a nonsense variant, which changes a Glutamine to a premature stop codon (CAG>TAG), and is predicted to cause loss of normal protein function through either protein truncation or nonsense-mediated mRNA decay. This variant has been reported in at least two individuals with colorectal cancer, one of whom also had a sebaceous neoplasm, and is considered pathogenic (Mangold 2007, Steinke 2008).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.